Label: CELL FUSION C LASER SUNSCREEN BROAD SPECTRUM SPF 50- homosalate, octisalate, titanium dioxide, zinc oxide cream
- NDC Code(s): 52554-9052-1, 52554-9052-2
- Packager: CMS LAB Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 1, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENTS
- PURPOSE
- USES
- WARNINGS
- DO NOT USE
- WHEN USING
- STOP USE
- KEEP OUT OF REACH OF CHILDREN
-
DIRECTIONS
For sunscreen use:
- apply generously and evenly 15 minutes before sun exposure
- reapply:
- after 80 minutes of swimming or sweating
- immediately after towel drying
- at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m.-2 p.m.
- wear long-sleeved shirts, pants, hats, and sunglasses
- children under 6 months of age: Ask a doctor
- OTHER INFORMATION
-
INACTIVE INGREDIENTS
WATER, CYCLOPENTASILOXANE, DIPROPYLENE GLYCOL, DISILOXANE, LAURYL PEG-10 TRIS(TRIMETHYLSILOXY) SILYLETHYL DIMETHICONE, GLYCERIN, BUTYLOCTYL SALICYLATE, SILICA, DIMETHICONE, DISTEARDIMONIUM HECTORITE, MAGNESIUM SULFATE, METHYL METHACRYLATE CROSSPOLYMER, 1,2-HEXANEDIOL, TRIETHOXYCAPRYLYLSILANE, STEARIC ACID, ALUMINUM HYDROXIDE, SORBITAN CAPRYLATE, DIMETHICONE/PEG-10/15 CROSSPOLYMER, LAVANDULA ANGUSTIFOLIA (LAVENDER) OIL, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, GLYCERYL CAPRYLATE, ETHYLHEXYLGLYCERIN, SODIUM CITRATE, HYDROXYDECYL UBIQUINONE, HYDROLYZED COLLAGEN, TOCOPHEROL, HYDROGENATED LECITHIN, CERAMIDE NP, SUCROSE STEARATE, CHOLESTEROL, CHOLESTERYL MACADAMIATE, PALMITIC ACID, BIOSACCHARIDE GUM-4, SACCHARIDE ISOMERATE, HYDROLYZED LUPINE PROTEIN
- QUESTIONS?
- PRINCIPAL DISPLAY PANEL: 50ML / 1.69 FL.OZ. Carton
-
INGREDIENTS AND APPEARANCE
CELL FUSION C LASER SUNSCREEN BROAD SPECTRUM SPF 50
homosalate, octisalate, titanium dioxide, zinc oxide creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:52554-9052 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 7.5 g in 50 mL ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 12.7 g in 50 mL OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 4.5 g in 50 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 2.2 g in 50 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:52554-9052-1 1 in 1 BOX 12/01/2024 1 50 mL in 1 TUBE; Type 0: Not a Combination Product 2 NDC:52554-9052-2 1 in 1 BOX 12/01/2024 2 10 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 12/01/2024 Labeler - CMS LAB Inc. (557795012) Registrant - CMS LAB Inc. (557795012)
